(LFSC) F/m Emerald Life Sciences - Ratings and Ratios

The F/m Emerald Life Sciences Innovation ETF (US:LFSC) is an actively managed exchange-traded fund (ETF) focused on equity securities of life science companies. The fund is advised by Emerald Mutual Fund Advisers Trust, with the investment sub-adviser selecting securities under the supervision of the adviser. Under normal market conditions, the ETF allocates at least 80% of its net assets to equity securities issued by life science companies demonstrating innovation. This includes firms involved in biotechnology, pharmaceuticals, and medical devices, among other subsectors. The funds active management strategy allows for dynamic adjustments based on market conditions and emerging opportunities in the life sciences sector.

The ETF is listed on a U.S. exchange and is categorized under the health sector. It has an average trading volume of 5,345 shares over a 20-day period, with a last price of $23.59 as of the latest data. The funds assets under management (AUM) total $52.46 million, indicating a moderate scale of operations. From a technical perspective, the ETFs short-term moving averages (SMA 20: $25.04, SMA 50: $24.83) suggest recent price fluctuations, while the SMA 200 ($25.16) reflects longer-term stability. The average true range (ATR) of 0.52 indicates manageable volatility.

3-Month Forecast: Based on the provided data, the ETF is expected to remain stable, with potential for modest growth. The convergence of the SMA 20, SMA 50, and SMA 200 near $25 suggests a possible rebound to this level. The low ATR of 0.52 indicates that price movements are likely to remain contained, with limited downside risk. Fundamentally, the AUM of $52.46 million provides a solid foundation for the funds operations, though inflows or outflows could influence performance. Overall, the ETF is positioned to benefit from continued innovation in the life sciences sector, with a focus on companies driving advancements in healthcare and biotechnology.